妊娠期静脉血栓栓塞治疗共识概要
该共识由西班牙内科学会、医学放射学会、血管介入放射学会及妇产科学会联合制定,更新妊娠期静脉血栓栓塞的治疗建议。低分子肝素为妊娠及哺乳期首选抗凝治疗;维生素K拮抗剂、直接口服抗凝药因致畸或出血风险禁用。系统性溶栓、机械取栓等再灌注技术仅用于血流动力学不稳定的肺栓塞。
要点
- 妊娠及哺乳期静脉血栓栓塞首选低分子肝素治疗
- 维生素K拮抗剂孕6-12周及孕晚期禁用
- 直接口服抗凝药妊娠及哺乳期禁用
核心结论
- 低分子肝素是妊娠期及哺乳期静脉血栓栓塞的首选抗凝治疗
- 维生素K拮抗剂在孕6-12周因胚胎病风险禁用,孕晚期因出血风险禁用
- 直接口服抗凝药因产前畸形风险在妊娠及哺乳期禁用
- 系统性溶栓或机械取栓仅用于血流动力学不稳定的肺栓塞
研究设计与样本
- 由西班牙内科学会、医学放射学会、血管介入放射学会及妇产科学会联合制定的共识文件
- 对妊娠患者静脉血栓栓塞治疗的最新证据进行全面回顾并更新当前推荐意见
诊断标准与关键数值
- 低分子肝素推荐为妊娠及哺乳期静脉血栓栓塞的首选抗凝治疗
- 维生素K拮抗剂在孕6-12周及孕晚期禁用的推荐
- 直接口服抗凝药在妊娠及哺乳期禁用的推荐
- 系统性溶栓或机械取栓仅用于血流动力学不稳定肺栓塞的推荐
临床应用与阅片要点
- 妊娠期及哺乳期静脉血栓栓塞应优先考虑低分子肝素抗凝
- 孕6-12周及孕晚期避免使用维生素K拮抗剂
- 妊娠及哺乳期不选用直接口服抗凝药
- 血流动力学不稳定的肺栓塞才考虑溶栓或机械取栓
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
INTRODUCTION: Low-molecular-weight heparin is the anticoagulant treatment of choice for managing venous thromboembolism (VTE) during pregnancy and lactation. Vitamin K antagonists are contraindicated between weeks 6-12 of gestation due to their association with a specific embryopathy, and during the third trimester due to the risk of bleeding. Direct oral anticoagulants are contraindicated during pregnancy and breastfeeding because of the risk of prenatal malformations. Reperfusion techniques, such as systemic thrombolysis or mechanical thrombectomy, are reserved for cases of pulmonary embolism with hemodynamic instability.
METHODS AND RESULTS: This consensus document, developed by the Spanish Societies of Internal Medicine, Medical Radiology, Vascular and Interventional Radiology, and Gynecology and Obstetrics, provides a comprehensive review of the most recent evidence on the treatment of VTE in pregnant patients and updates current recommendations.
引用
- Fidalgo-Fernández, Ortiz, Moragón-Ledesma, et al. Executive summary of the consensus document for recommendations on the treatment of venous thromboembolism in pregnancy: consensus document from the Spanish Society of Internal Medicine, the Spanish Society of Medical Radiology, the Spanish Society of Vascular Interventional Radiology and the Spanish Society of Gynecology and Obstetrics 2026. Rev Clin Esp (Barc). 2026. PMID: 42586421. doi:10.1016/j.rceng.2026.502613
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。